戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  sufficient for mature biofilm formation and catheter infection.
2 al jugular accesses lead to similar risks of catheter infection.
3 s with 5-fluorouracil may reduce the risk of catheter infection.
4 n thinking of strategies designed to prevent catheter infection.
5 ally associated with abdominal infection and catheter infection.
6 ng the ability to exterminate an established catheter infection.
7 enation cannula infection, and one pulmonary-catheter infection.
8 n vivo grown biofilms using a mouse model of catheter infection.
9         Candida species are a major cause of catheter infections.
10 s, in the treatment of S. aureus intravenous catheter infections.
11 rapeutic interventions, and risk factors for catheter infections.
12 albicans oropharyngeal, systemic, and venous catheter infections.
13                             The incidence of catheter infection (4.01/1,000 catheter days, 2.29% cath
14 nown on causative pathogens of intravascular catheters infection according to the catheter insertion
15 ine the prevalence of peripheral intravenous catheter infection and all-cause failure.
16 vely studied the incidence of central venous catheter infection and colonization at the subclavian, i
17  population, the incidence of central venous catheter infection and colonization is low overall and,
18 are needed to address peripheral intravenous catheter infection and failure and the sequelae of treat
19 educed P. aeruginosa and other Gram-negative catheter infections and reduced peritonitis by 35%, part
20 ons included wound infections (62%), central catheter infections and/or bacteremia (16%), and possibl
21 ay reduce the rate of complications (such as catheter infection) and favor renal function recovery.
22 f transplant recipients had life-threatening catheter infections, and 13 (65%) had a significant decr
23  treatments, the complications of tumors and catheters, infections, and thrombosis.
24 treatments, the complications of tumours and catheters, infections, and thrombosis.
25 oplasmosis infection; two Tenchkoff dialysis catheter infections; and fever (38.7 degrees C) during i
26                       Central nervous system catheter infections are a serious complication in the tr
27 prevents biofilm formation in a rat model of catheter infection by C. albicans.
28 on site dressings are a major mean to reduce catheter infections by the extraluminal route.
29  0.5), multiple comorbidities, pneumonia and catheter infection, coexistent infection with antibiotic
30             In a mouse model of jugular vein catheter infection, dabigatran reduced bacterial load on
31              The proportion of intravascular catheter infections due to nonfermenting Gram-negative b
32       Sak also attenuated biofilm-associated catheter infections in mouse models.
33 aphylococcal and enterococcal central venous catheter infections in rats, and 24-hour postprophylaxis
34                         The possibility that catheter infection is associated with gene polymorphisms
35 catheter-related thromboses include previous catheter infections, malposition of the catheter tip, an
36 ybrid biofilm both in vitro and in vivo in a catheter infection model.
37 ection when used in a CLS rat central venous catheter infection model.
38 achment of S. aureus biofilms in an in vitro catheter-infection model by using time-lapse microscopy.
39                   Per peripheral intravenous catheter, infection occurrence was low, however, with ov
40 bacterial device can be used to both prevent catheter infections or can be inserted within an infecte
41      Catheter-related thromboses can lead to catheter infection, pulmonary embolism, and post-thrombo
42                                              Catheter infection rates were 0.23/yr with gentamicin cr
43                                              Catheter infection rates were determined per 1,000 cathe
44 rmed biofilms and achieved cell densities in catheter infection studies that were equivalent to those
45                  There were no P. aeruginosa catheter infections using gentamicin compared with 0.11/
46                                Time to first catheter infection was longer using gentamicin (P = 0.03
47                                  The rate of catheter infection was not correlated with self-reported
48 /m2 as the maximum-tolerated dose (MTD), but catheter infection was the only significant complication
49              One hundred twenty-four central catheter infections were reported in 41 subjects (19 LD)
50 C. albicans biofilm-associated intravascular catheter infections, which warrants further study.
51                                              Catheter infection with E. cloacae occurred in 50% of ro
52 ive was to assess the risk of central venous catheter infection with respect to the site of insertion
53                                              Catheter infection with S. epidermidis occurred in 32% o